This may be because of biological differences, such as the existence of multiple subtypes of breast cancer, with different intrinsic snoRNA levels, and variation among samples induced by ER and HER2 status, the heterogeneity in HNSCC site subtypes and differences in relative amounts of tumour and stromal tissue between samples. This evidence concerns the gene ERBB2 and neoplasm.